(Q40320009)
Statements
1 reference
A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer (English)
1 reference
Kostyantyn Krysan
1 reference
Jason D Morrow
1 reference
Robert A Newman
1 reference
Christopher Tucker
1 reference
Robert M Elashoff
1 reference
Steven M Dubinett
1 reference
Robert A Figlin
1 reference
1 June 2006
1 reference
1 reference
12
1 reference
11 Pt 1
1 reference
3381-3388
1 reference
Identifiers
1 reference
1 reference